Follow-up Study to Evaluate Sustained Clearance Rates of Actinic Keratoses up to One Year

Investigating the Effect of Topical Imiquimod on Sebaceous Hyperplasia

NCT06840470 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4

Study of Imiquimod Cream Prior to Ablative Therapy in External Ano-Genital Warts

NCT00189293 ·Status: COMPLETED ·Phase: PHASE4

Efficacy and Safety of a New Topical Formulation With Imiquimod (Limtop) Applied 1, 3 or 7 Times Weekly During 2 x 2 Weeks Treatment for Actinic Keratosis on the Head

NCT01611480 ·Status: COMPLETED ·Phase: PHASE2

Topical Imiquimod in Conjunction With Nd:YAG Laser for Tattoo Removal

NCT00638651 ·Status: COMPLETED ·Phase: PHASE1

Comparing Immune Responses to Topical Imiquimod

NCT04809662 ·Status: TERMINATED

Study of A-101 Topical Solution for the Treatment of Common Warts

NCT03687372 ·Status: COMPLETED ·Phase: PHASE3

Combination Therapy of Imiquimod 5%Cream and Cryotherapy vs Monotherapy for Common Warts:Randomized Comparative Trial.

NCT06973473 ·Status: NOT_YET_RECRUITING

Study With a Topical Gel to Treat Common Warts in Adults

NCT00117871 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Effectiveness of Imiquimod 5% Cream for Basal Cell Carcinoma Recurrence

NCT00129519 ·Status: COMPLETED ·Phase: PHASE3

Impact of Human Papillomavirus (HPV) Vaccination on Burden of Disease in Patients with Actinic Keratosis

NCT05202860 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

A Study of A-101 Topical Solution for the Treatment of Common Warts

NCT03691831 ·Status: COMPLETED ·Phase: PHASE3

Study to Investigate the Efficacy, Safety, and Tolerability of Topical HT-001 for the Treatment of Skin Toxicities Associated With Epidermal Growth Factor Receptor Inhibitors

NCT05639933 ·Status: RECRUITING ·Phase: PHASE2

A First-in-human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of LFX453

NCT02052687 ·Status: COMPLETED ·Phase: PHASE1

Topical Challenge With Omiganan and Imiquimod in Healthy Volunteers

NCT03071679 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate Effectiveness of Imiquimod 5% Cream in Superficial Basal Cell Carcinoma

NCT00189241 ·Status: COMPLETED ·Phase: PHASE3

A Pilot Study of the Treatment of Facial Nodular and Nodulocystic Basal Cell Carcinoma With Double Curettage and Cautery Followed by Application of Imiquimod to the Base

NCT00463359 ·Status: UNKNOWN ·Phase: NA

Laser Versus Cryotherapy for the Treatment of Recalcitrant Warts

NCT05616078 ·Status: NOT_YET_RECRUITING ·Phase: NA

A Study of A-101 Topical Solution Administered Twice a Week in Subjects With Common Warts

NCT03278028 ·Status: COMPLETED ·Phase: PHASE2

Twelve Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Adults

NCT00114920 ·Status: COMPLETED ·Phase: PHASE2

Treatment of Plane Warts With Topical and Oral Retinoids

NCT07012811 ·Status: COMPLETED ·Phase: PHASE4

Topical Imiquimod Compared With Surgery in Treating Patients With Basal Cell Skin Cancer

NCT00066872 ·Status: COMPLETED ·Phase: PHASE3

A Double-blind, Randomized, Single Centre, Vehicle-controlled Study to Evaluate the Safety and Tolerability of a New Topical Formulation Containing 0,09% Imiquimod (Limtop) in Healthy Subjects

NCT01567683 ·Status: COMPLETED ·Phase: PHASE1

Safety and Effectiveness Study of Imiquimod Creams in the Treatment of External Genital Warts

NCT00674739 ·Status: COMPLETED ·Phase: PHASE3

Four Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Adults

NCT00115141 ·Status: COMPLETED ·Phase: PHASE2

An up to Twelve Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Pediatric Subjects

NCT00116662 ·Status: COMPLETED ·Phase: PHASE2